Leading academics and innovators join refreshed BioEscalator Management Board
In its first major refresh since establishment in 2018, the BioEscalator is delighted to welcome four leading University of Oxford academics and innovators to its Management Board. Professors Catherine Green OBE, Beth Psaila, Molly Stevens DBE and Krina Zondervan are joining alongside a fifth new member, Peter Callow, Financial Controller of the Medical Sciences Division at the University of Oxford.
The Management Board provides a source of expertise for BioEscalator tenants and works to enhance research at the University by building strong links with small life sciences companies.
Peter Callow is a seasoned finance executive with extensive international experience in financial management, strategic planning, and leadership.
Professor Catherine Green OBE is Head of the Clinical Biomanufacturing Facility at Nuffield Department of Medicine and Associate Professor in Chromosome Dynamics at the Centre for Human Genetics, University of Oxford. She played a key role in developing the Oxford/AstraZeneca Covid-19 vaccine.
Professor Bethan Psaila is Associate Professor of Haematology and Cancer Research, MRC Weatherall Institute of Molecular Medicine, University of Oxford; she is also Co-founder of blood malignancies company and BioEscalator tenant Alethiomics.
Professor Molly Stevens DBE is John Black Professor of Bionanoscience, University of Oxford and Research Director for Biomedical Materials, Imperial College London.
Professor Krina Zondervan is Head of the Nuffield Department of Women’s & Reproductive Health and Professor of Reproductive and Genomic Epidemiology and Co-Director of the Endometriosis Care Centre, University of Oxford.
‘These five new Board members bring a wealth of medical sciences expertise and skills to the BioEscalator, which will have a positive impact on tenants and the University of Oxford research activity. We welcome them to the Management Board and look forward to working with them on innovation activities’
Professor of Neuroscience and Entrepreneur Matthew Wood, Chair of the Board
